Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Mar'25
Sep'24
Mar'24
Sep'23
Mar'23
Sep'22
Net Sales
203.59
182.05
180.30
154.45
141.27
114.72
112.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
203.59
182.05
180.30
154.45
141.27
114.72
112.39
Raw Material Cost
104.53
87.96
87.82
87.94
79.71
57.10
53.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-5.49
-1.71
-2.72
-7.57
-10.67
-4.92
0.21
Employee Cost
19.23
17.68
16.29
13.78
12.11
11.76
10.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
25.15
21.77
18.85
16.69
15.09
11.98
11.83
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
19.16
20.56
21.26
16.47
12.17
12.48
9.31
Total Expenditure (Excl Depreciation)
162.58
146.26
141.50
127.31
108.41
88.40
85.59
Operating Profit (PBDIT) excl Other Income
41.01
35.79
38.80
27.14
32.86
26.32
26.80
Other Income
5.98
4.93
1.51
0.82
0.54
0.43
0.33
Operating Profit (PBDIT)
46.99
40.72
40.31
27.96
33.40
26.75
27.13
Interest
6.93
5.16
1.83
1.45
1.37
1.27
1.14
Exceptional Items
0.00
-4.57
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
40.06
30.99
38.48
26.51
32.03
25.48
25.99
Depreciation
7.97
6.80
5.71
4.34
5.44
5.58
4.83
Profit Before Tax
32.09
24.19
32.78
22.17
26.58
19.90
21.16
Tax
8.17
6.21
8.34
5.61
6.71
5.01
5.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.92
17.98
24.44
16.56
19.87
14.88
15.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.92
17.98
24.44
16.56
19.87
14.88
15.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.92
17.98
24.44
16.56
19.87
14.88
15.83
Equity Capital
10.09
10.09
9.61
9.61
9.61
9.61
9.61
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
210.92
187.00
171.25
147.50
13.24
113.27
98.41
Earnings per share (EPS)
23.71
17.82
24.22
16.41
20.68
15.48
16.47
Diluted Earnings per share
47.38
17.81
24.21
16.41
20.67
15.48
16.47
Operating Profit Margin (Excl OI)
20.14%
19.66%
21.52%
17.57%
23.26%
22.94%
23.85%
Gross Profit Margin
19.68%
17.02%
21.34%
17.16%
22.67%
22.21%
23.12%
PAT Margin
11.75%
9.88%
13.56%
10.72%
14.07%
12.97%
14.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 11.83% vs 0.97% in Mar 2025
Consolidate Net Profit
Growth in half year ended Sep 2025 is 33.04% vs -26.43% in Mar 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 14.59% vs -7.76% in Mar 2025
Interest
Growth in half year ended Sep 2025 is 34.30% vs 181.97% in Mar 2025
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Mar 2025
Compare Half Yearly Results Of Beta Drugs Ltd With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
203.59
0
203.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
203.59
0
203.59
Raw Material Cost
104.53
0
104.53
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-5.49
0
-5.49
Employee Cost
19.23
0
19.23
Power Cost
0.00
0
0.00
Manufacturing Expenses
25.15
0
25.15
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
19.16
0.00
19.16
Total Expenditure (Excl Depreciation)
162.58
0
162.58
Operating Profit (PBDIT) excl Other Income
41.01
0.00
41.01
Other Income
5.98
0
5.98
Operating Profit (PBDIT)
46.99
0
46.99
Interest
6.93
0
6.93
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
40.06
0
40.06
Depreciation
7.97
0
7.97
Profit Before Tax
32.09
0
32.09
Tax
8.17
0
8.17
Provisions and contingencies
0.00
0
0.00
Profit After Tax
23.92
0
23.92
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
23.92
0
23.92
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.92
0
23.92
Equity Capital
10.09
0
10.09
Face Value
10.00
0
0.00
Reserves
210.92
0
210.92
Earnings per share (EPS)
23.71
0
23.71
Diluted Earnings per share
47.38
0
47.38
Operating Profit Margin (Excl OI)
20.14%
0%
0.00
20.14%
Gross Profit Margin
19.68%
0%
0.00
19.68%
PAT Margin
11.75%
0%
0.00
11.75%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 203.59 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 11.83% vs 0.97% in Mar 2025
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 23.92 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 33.04% vs -26.43% in Mar 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.01 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 14.59% vs -7.76% in Mar 2025
Half Yearly - Interest
Interest 6.93 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 34.30% vs 181.97% in Mar 2025
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.14%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
